Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders.

Schmidt, A Floriaan; Finan, Chris; Chopade, Sandesh; Ellmerich, Stephan; Rossor, Martin N; Hingorani, Aroon D; Pepys, Mark B

Schmidt, A Floriaan; Finan, Chris; Chopade, Sandesh; Ellmerich, Stephan; Rossor, Martin N; Hingorani, Aroon D; Pepys, Mark B.

Afiliación

Schmidt AF; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom.
Finan C; UCL British Heart Foundation Research Accelerator, London, United Kingdom.
Chopade S; Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
Ellmerich S; Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Rossor MN; Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom.
Hingorani AD; UCL British Heart Foundation Research Accelerator, London, United Kingdom.
Pepys MB; Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

medRxiv ; 2023 Aug 16.

Article en En | MEDLINE | ID: mdl-37645746

Palabras clave

Alzheimer's disease; Lewy body dementia; Mendelian randomization; dementia; genome-wide association study; miridesap; neurodegeneration; serum amyloid P component

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: MedRxiv Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google